Johnson & Johnson vaccine next in line for MedSafe approval
Dr Ashley Bloomfield said approval could come as soon as mid-April.
Julie Iles
Thu, 04 Mar 2021
Director-General of Health Dr Ashley Bloomfield has today said that the Johnson & Johnson/Janssen vaccine is likely to be the next cab off the ranks in New Zealand's vaccine portfolio.
Speaking to reporters today at the Ministry of Health, Bloomfield said the Janssen vaccine was the "next most
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Julie Iles
Thu, 04 Mar 2021
Contact the Writer: julie@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Johnson & Johnson vaccine next in line for MedSafe approval
Politics,
86577